Loading organizations...
§ Private Profile · Hangzhou, Zhejiang, China
Developers of drugs for treating metabolic disorders.
Sciwind Biosciences has raised $37.0M across 1 funding round.
Sciwind Biosciences has raised $37.0M in total across 1 funding round.
Sciwind Biosciences has raised $37.0M across 1 funding round. Most recently, it raised $37.0M Series B in February 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 19, 2021 | $37M Series B | Lyfe Capital | Legend Capital | Announced |
Sciwind Biosciences has raised $37.0M in total across 1 funding round.
Sciwind Biosciences's investors include LYFE Capital, Legend Capital.